Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen a doctor prescribes weight loss injections, they are working through a structured clinical assessment — checking your medical history, current medications, BMI, and any conditions that might affect safety or suitability. Both licensed options in the UK, Mounjaro (tirzepatide) and Wegovy (semaglutide), are prescription-only medicines. That means a qualified prescriber must review your case before a single pen is dispensed — and that review is the point, not a formality.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
There is a widely held assumption that weight loss injections are straightforward top-ups, like a vitamin shot. They are not. Mounjaro and Wegovy work on receptors that regulate appetite, blood sugar, and gastric emptying. That mechanism is effective precisely because it alters how your body functions, and that is exactly why the MHRA classifies them as prescription-only medicines under UK law.
A prescriber reviewing your case is looking at the whole picture: your current weight and BMI, any conditions you already have (type 2 diabetes, high blood pressure, sleep apnoea), the medicines you take now, and whether anything in your history makes these treatments unsuitable. For example, a personal or close family history of medullary thyroid carcinoma is a contraindication; so is pregnancy. People planning surgery also need to tell their anaesthetist they are on a GLP-1 medicine, because these treatments affect gastric emptying, something NHS England specifically flags in its guidance on weight management injections.
The assessment is not bureaucracy for its own sake. It is the thing that separates treatment from risk.
Whether you see a GP or use a regulated online service, the clinical steps are essentially the same. You provide a full medical history, detail your current medications, and confirm your weight. Identity is verified. A prescriber reviews everything (not software) and either approves treatment, requests more information, or explains why this treatment is not right for you at this time.
At nume, that review is carried out the same day by a GPhC-registered Independent Prescriber. Live video weight verification and photo ID are part of every new patient assessment. That is not a box-ticking exercise; it is what responsible dispensing looks like. Transfer patients are asked to provide evidence of their current treatment and most recent dose.
Once approved, the treatment is dispatched the same day (for orders placed before 12pm, Monday to Friday) and delivered free by DPD the next working day, in plain unbranded packaging. If you have questions about what the process involves, the FAQs page covers the most common ones.
You can also read more about the steps involved in obtaining weight loss injections through a regulated UK pharmacy.
The most common effects are gastrointestinal: nausea, loose stools, constipation, acid reflux, and burping. These tend to be most noticeable in the first week or two after starting or after a dose increase, and they usually settle. Starting at the lowest dose and moving up gradually is the main way prescribers manage this, which is why the titration schedule exists.
Less common but more urgent: severe stomach pain that spreads toward the back, with or without vomiting, can be a sign of acute pancreatitis. In January 2026, the MHRA issued a Drug Safety Update reminding patients and clinicians that pancreatitis, while infrequent, is a known and potentially serious side effect of GLP-1 medicines. If that happens, stop the injection and get medical help straight away, do not wait for a scheduled review.
Women using oral contraceptives should be aware that tirzepatide (Mounjaro) can reduce absorption of the pill during the first four weeks of treatment and for four weeks after each dose increase. Adding a non-oral contraceptive method during those windows is recommended. NHS guidance does not flag the same interaction for semaglutide (Wegovy), though prescribers weigh this case by case.
Any suspected side effect can be reported directly to the MHRA via the Yellow Card scheme. Legitimate prescribers actively encourage this; it is part of how medicine safety evidence grows over time. It is also worth reading what UK doctors have said about the risks of weight loss injections, particularly if you are weighing up whether treatment is right for you.
Both routes exist. Some GP practices, particularly from April 2026 under the new GP contract, can now prescribe tirzepatide directly, though participation varies by practice and area, and NHS eligibility thresholds are strict. Many people find their GP is not yet offering this, or that they do not meet the current NHS criteria (which are phased, with the broadest access still several years away for most BMI ranges).
Private options fill that gap. Finding a prescriber near you is one route, though regulated online pharmacies registered with the GPhC offer the same clinical rigour without geography as a constraint. You can verify any online pharmacy on the GPhC register, the registration number should be easy to find. If it is not displayed, that is worth noting.
On pricing: the cost of treatment varies between providers, and it is worth understanding what a quoted price actually includes, prescription fees, delivery, and clinical aftercare are sometimes added separately. nume's pricing is single and transparent, covering consultation, prescription, treatment, delivery, and 7-day aftercare. There are no subscriptions and no auto-renewals. If you want to understand your options, checking your eligibility is a straightforward next step with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.